Marimed (MRMD) Non-Current Debt (2012 - 2026)
Marimed (MRMD) posted quarterly Non-Current Debt of $173000.0 for Q1 2026, up 8.13% year-over-year from $160000.0 in Q1 2025, and down 6.49% quarter-over-quarter from $185000.0 in Q4 2025.
Marimed (MRMD) Non-Current Debt (2012 - 2026) Analysis & Trends
Marimed (MRMD) has reported Non-Current Debt for 14 consecutive years, with $173000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt rose 8.13% year-over-year to $173000.0; the TTM figure through Mar 2026 stood at $173000.0 (up 8.13% YoY), while the FY2025 annual figure was $185000.0, up 3.93% from the prior year.
- Non-Current Debt fell to $173000.0 in Q1 2026 per MRMD's latest filing, from $185000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $31.2 million in Q3 2023 and bottomed at $46000.0 in Q1 2022.
- Historically, Non-Current Debt has averaged $5.0 million across 5 years, with a median of $178000.0 in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Debt slumped 99.72% — and 2023, when it soared 45123.91%.
- Marimed's Non-Current Debt stood at $48000.0 in 2022, then soared by 270.83% to $178000.0 in 2023, then changed by 0.0% to $178000.0 in 2024, then gained by 3.93% to $185000.0 in 2025, then dropped by 6.49% to $173000.0 in 2026.
- Business Quant data shows MRMD's Non-Current Debt at $173000.0 in Q1 2026, $185000.0 in Q4 2025, and $352000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 352,000.00 |
| Mar 31, 2026 | 173,000.00 |
| Dec 31, 2025 | 185,000.00 |
| Sep 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 151,000.00 |
| Mar 31, 2025 | 160,000.00 |
| Dec 31, 2024 | 178,000.00 |
| Sep 30, 2024 | 177,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 148,000.00 |
| Dec 31, 2023 | 178,000.00 |
| Sep 30, 2023 | 31.18 Mn |
| Jun 30, 2023 | 20.55 Mn |
| Mar 31, 2023 | 20.80 Mn |
| Dec 31, 2022 | 48,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 17.26 Mn |
| Sep 30, 2021 | 925,871.00 |
| Jun 30, 2021 | 2.02 Mn |
| Mar 31, 2021 | 3.24 Mn |